title: A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job.
abstract: MicroRNAs (miRNAs) are short, endogenous, noncoding RNA molecules that regulate gene expression at a post-translational level. MiRNAs have been recognized in the regulation of physiological conditions. Moreover, awareness of the association between dysregulated miRNAs and human diseases is increasing, which consequently brings miRNAs to the frontline in the development of novel therapeutic strategies. We review the latest advances in our knowledge of the involvement of miRNAs in fibrosis with particular emphasis on hepatic fibrosis and the possibilities in the near future for miRNA-based therapy for targeted treatment of liver fibrosis. With recent advances in our understanding of the important role of senescence in the resolution of activated hepatic stellate cells (HSCs), we suggested the therapeutic potential of inducing activated HSCs into senescence by an miRNA-based strategy.
authors: Department of Infection and Liver Diseases, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China.
authors: Shao-Long
authors: SL
authors: Chen
authors: Ming-Hua
authors: MH
authors: Zheng
authors: Ke-Qing
authors: KQ
authors: Shi
authors: Tao
authors: T
authors: Yang
authors: Yong-Ping
authors: YP
authors: Chen
mesh_terms: D000818:Animals; D016922:Cellular Senescence; D018014:Gene Transfer Techniques; D055166:Hepatic Stellate Cells / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D008103:Liver Cirrhosis / Q000473:pathology / Q000628:therapy*; D035683:MicroRNAs / Q000008:administration & dosage / Q000235:genetics* / Q000378:metabolism; D058990:Molecular Targeted Therapy / Q000379:methods*
chemical_list: D035683:MicroRNAs